EVE Completes Initial Production of Libbo
Filed with ASX · · 2 pages · English
• Manufacture of Libbo™, EVE’s oral dissolving film treatment for erectile dysfunction, completed and inventory delivered to national distributor. • Distribution, quality and fulfilment systems now in place, supporting imminent market entry. • Enables near-term commencement of prescribing and patient access via telehealth and pharmacy channels. • The Libbo™ oral dissolving film format is designed
EVE Health Group Limited on 6ix
Story so far
Earlier from EVE Health
- EVE Signs Telehealth Services Agreement with hubMed -Revised
- EVE Signs Telehealth Services Agreement with hubMed
- Medical Science Liaison Appointed
- EVE Raises $1.1m to Accelerate Launches of Dyspro and Libbo
- Dyspro Prescribed to First Patients
Later from EVE Health
- Quarterly Activities/Appendix 4C Cash Flow Report
- Launch of Libbo and Activation of Men's Health Platform
- Appendix 4D and Half Year Report
- EVE Advances Reformulated Drugs Targeting Global Markets
- Trading Halt
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health